Since SB3 is strictly associated with HIF2α regulation (25), here we investigated whether, beside a pro-fibrogenic action, SB3 might have pro-inflammatory role in NAFLD/NASH. Here, EPAS1 is linked to metabolic dysfunction-associated steatotic liver disease.